Status:
ACTIVE_NOT_RECRUITING
Evaluating Telementoring for CHW-centered Diabetes Initiatives
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Collaborating Sponsors:
The University of Texas Health Science Center, Houston
University of Houston
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Diabetes care is complex and requires a multidimensional approach, but interventional programs are difficult to initiate in low-income and minority populations. In the proposed study, investigators wi...
Detailed Description
Diabetes is a major public health problem in Latino(a)s. There are escalating numbers of Latino(a)s diagnosed with diabetes and at disproportionate rates compared to other ethnicities. Numerous interv...
Eligibility Criteria
Inclusion
- self-identified Latino(a)
- Spanish-speaking
- \>/=18 years
- type 2 diabetes (T2D), e.g., HbA1c \>/=6.5%, provider documented T2D, on oral anti-hyperglycemic
- uninsured, \<150% federal poverty level
Exclusion
- no show to all group visits
- condition that may alter HbA1c levels, e.g., recent blood transfusion
- patients at high-risk or not appropriate for care in a group setting e.g., pregnancy, severe cognitive impairment, frequent clinic appointments for labile glucose/medication titration e.g., insulin.
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2028
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT04835493
Start Date
September 1 2022
End Date
July 31 2028
Last Update
June 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Medical Branch
Houston, Texas, United States, 77030